137 related articles for article (PubMed ID: 6159518)
1. [Clinical experiences with phyto-therapy of benign prostatic hypertrophy].
Bauer KM
Med Welt; 1980 Aug; 31(34):1211-4. PubMed ID: 6159518
[No Abstract] [Full Text] [Related]
2. [Clinical evaluation of Cernilton in benign prostatic hypertrophy].
Hayashi J; Mitsui H; Yamakawa G; Suga A; Kai A; Shimabukuro T; Yanagi K; Fujisawa S; Takihara H; Kaneda Y
Hinyokika Kiyo; 1986 Jan; 32(1):135-41. PubMed ID: 2421560
[TBL] [Abstract][Full Text] [Related]
3. [Conservative therapy of prostatic hyperplasia with urinary retention].
Djulepa J
Med Welt; 1983 Dec; 34(48):1377-9. PubMed ID: 6197601
[No Abstract] [Full Text] [Related]
4. [Clinical evaluation of cernilton in the treatment of the benign prostatic hypertrophy].
Horii A; Iwai S; Maekawa M; Tsujita M
Hinyokika Kiyo; 1985 Apr; 31(4):739-46. PubMed ID: 2412423
[TBL] [Abstract][Full Text] [Related]
5. [Medical treatment of fibroadenomatous hypertrophy of the prostate with a new plant substance].
Maver A
Minerva Med; 1972 May; 63(37):2126-36. PubMed ID: 4113157
[No Abstract] [Full Text] [Related]
6. [Clinical effect of the drug "Prostamol-Uno" in patients with benign prostatic hyperplasia and chronic prostatitis].
Mazo EB; Dmitriev DG
Urologiia; 2001; (5):38-41. PubMed ID: 11641979
[No Abstract] [Full Text] [Related]
7. [Clinical effect of PPC for the palliative treatment of benign prostatic hypertrophy].
Ishigami J; Kuroda K
Hinyokika Kiyo; 1969 Jan; 15(1):68-75. PubMed ID: 4180035
[No Abstract] [Full Text] [Related]
8. African plum and benign prostatic hypertrophy.
Strong KM
J Herb Pharmacother; 2004; 4(1):41-6. PubMed ID: 15273076
[No Abstract] [Full Text] [Related]
9. [Monitoring the effectiveness of conservative treatment of benign prostatic hypertrophy by means of uroflowmetry].
Tunn U; Senge T
Z Urol Nephrol; 1978 Aug; 71(8):521-8. PubMed ID: 83057
[TBL] [Abstract][Full Text] [Related]
10. [Effect of prostamol-Uno on oxidative and local immune status in patients with benign prostatic hyperplasia and chronic prostatitis].
Seregin SP; Bratchikov OI; Konoplia AI; Shestakov SG; Dolzhenkov SD; Novikov AV; Shatokhin MN; Kotov AV
Urologiia; 2002; (4):14-6. PubMed ID: 12357892
[TBL] [Abstract][Full Text] [Related]
11. Saw palmetto extracts for benign prostatic hyperplasia.
Segars LW
J Fam Pract; 1999 Feb; 48(2):88-9. PubMed ID: 10037530
[No Abstract] [Full Text] [Related]
12. [Tadenan treatment of prostatic adenoma].
Danilov VV; Elisseva EV; Vasil'chenko AV
Urologiia; 2009; (2):68, 70-3. PubMed ID: 19526878
[TBL] [Abstract][Full Text] [Related]
13. [Non-surgical treatment of benign prostatic hypertrophy].
Martini E; Vaggi L; Rucci A; Di Clemente L
J Chir (Paris); 1994 Oct; 131(10):445-9. PubMed ID: 7532181
[No Abstract] [Full Text] [Related]
14. [Tumorous prostatic diseases. I. Prostatic adenoma--genesis, clinical aspects, therapy].
Reichelt H
Z Allgemeinmed; 1974 May; 50(15):688-93. PubMed ID: 4137484
[No Abstract] [Full Text] [Related]
15. [Tadenan (Pygeum africanum extract) in the treatment of patients with benign prostatic hyperplasia].
Urologiia; 2004; (5):70-2. PubMed ID: 15560171
[No Abstract] [Full Text] [Related]
16. [Treatment of prostatic hypertrophy with eviprostat].
Kubo Y; Inoue S; Ono T; Yasui A
Hinyokika Kiyo; 1966 Dec; 12(12):1463-7. PubMed ID: 4167083
[No Abstract] [Full Text] [Related]
17. Re: a phase II randomised double-blind placebo-controlled clinical trial investigating the efficacy and safety of ProstateEZE Max: a herbal medicine preparation for the management of symptoms of benign prostatic hypertrophy.
Kaplan SA
J Urol; 2014 Jul; 192(1):164. PubMed ID: 25629105
[No Abstract] [Full Text] [Related]
18. [Use of a preparation with pollen extract base in patients with prostatic hypertrophy].
Inada T; Kitagawa T; Miyakawa M
Clin Ter; 1970 Jun; 53(5):431-8. PubMed ID: 4097408
[No Abstract] [Full Text] [Related]
19. [Drug therapy of benign prostatic hyperplasia. Pumpkin et al. in the front line].
MMW Fortschr Med; 2000 Jul; 142(30):53. PubMed ID: 10955026
[No Abstract] [Full Text] [Related]
20. [The clinical effects of SH 582 (gestonorone caproate) on benign prostatic hypertrophy].
Momose S; Hidaka M; Oota Y; Oomaru K
Hinyokika Kiyo; 1970 Sep; 16(9):551-4. PubMed ID: 4097366
[No Abstract] [Full Text] [Related]
[Next] [New Search]
